Brief: Active Biotech: Patent To Be Granted In U.S.
25/11/2025 09:26
Nov 25 (Reuters) - Active Biotech AB publ ACTI.ST: ACTIVE BIOTECH’S PATENT RELATED TO A PHARMACEUTICAL FORMULATION OF TASQUINIMOD WILL BE GRANTED IN THE US PATENT WILL PROVIDE PROTECTION AND MARKET EXCLUSIVITY UNTIL 2042. Source text: ID:nMFN1N2DC6 Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))